Meng T. Fan

State Key Laboratory Of Bioreactor Engineering
Shanghai, 200237, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Inhibiting the NLRP3 inflammasome with MCC950 ameliorates muscle atrophy in cancer cachexia.

Inhibiting the NLRP3 inflammasome with MCC950 ameliorates muscle atrophy in cancer cachexia.

Journal: European journal of pharmacology

Published: November 21, 2025

Exosomes in organ transplantation: roles in immunomodulation, ferroptosis and mitophagy.

Exosomes in organ transplantation: roles in immunomodulation, ferroptosis and mitophagy.

Journal: Frontiers in immunology

Published: October 15, 2025

The potential of TAOK1 as a new therapeutic target for the treatment of cancer cachexia-associated muscle atrophy.

The potential of TAOK1 as a new therapeutic target for the treatment of cancer cachexia-associated muscle atrophy.

Journal: Pharmacological research

Published: December 13, 2024

The involvement and possible targeting of cardiolipins degradation and disturbed linoleic acid metabolism in cardiac atrophy under cancer cachexia.

The involvement and possible targeting of cardiolipins degradation and disturbed linoleic acid metabolism in cardiac atrophy under cancer cachexia.

Journal: European journal of pharmacology

Published: July 16, 2024

Diagnosis and differential diagnosis of large B-cell lymphoma with IRF4 rearrangement

Diagnosis and differential diagnosis of large B-cell lymphoma with IRF4 rearrangement

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: June 03, 2024

Compound Z526 alleviates chemotherapy-induced cachectic muscle loss by ameliorating oxidative stress-driven protein metabolic imbalance and apoptosis.

Compound Z526 alleviates chemotherapy-induced cachectic muscle loss by ameliorating oxidative stress-driven protein metabolic imbalance and apoptosis.

Journal: European journal of pharmacology

Published: December 21, 2023

A novel FAK-degrading PROTAC molecule exhibited both anti-tumor activities and efficient MDR reversal effects.

A novel FAK-degrading PROTAC molecule exhibited both anti-tumor activities and efficient MDR reversal effects.

Journal: Acta pharmacologica Sinica

Published: December 08, 2023

Carnosol ameliorated cancer cachexia-associated myotube atrophy by targeting P5CS and its downstream pathways.

Carnosol ameliorated cancer cachexia-associated myotube atrophy by targeting P5CS and its downstream pathways.

Journal: Frontiers in pharmacology

Published: September 08, 2023

Novel oral compound Z526 mitigates cancer-associated cachexia via intervening NF-κB signaling and oxidative stress.

Novel oral compound Z526 mitigates cancer-associated cachexia via intervening NF-κB signaling and oxidative stress.

Journal: Genes & diseases

Published: August 02, 2023

Corylifol A ameliorates muscle atrophy by inhibiting TAOK1/p38-MAPK/FoxO3 pathway in cancer cachexia.

Corylifol A ameliorates muscle atrophy by inhibiting TAOK1/p38-MAPK/FoxO3 pathway in cancer cachexia.

Journal: Journal of cachexia, sarcopenia and muscle

Published: December 15, 2022

Micro-electrochemical DO sensor with ultra-micropore matrix fabricated with femtosecond laser processing successfully applied in on-line DO monitoring for yeast culture.

Micro-electrochemical DO sensor with ultra-micropore matrix fabricated with femtosecond laser processing successfully applied in on-line DO monitoring for yeast culture.

Journal: Biotechnology letters

Published: July 04, 2022

Carnosol attenuated atrophy of C2C12 myotubes induced by tumour-derived exosomal miR-183-5p through inhibiting Smad3 pathway activation and keeping mitochondrial respiration.

Carnosol attenuated atrophy of C2C12 myotubes induced by tumour-derived exosomal miR-183-5p through inhibiting Smad3 pathway activation and keeping mitochondrial respiration.

Journal: Basic & clinical pharmacology & toxicology

Published: February 21, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026